1. Home
  2. ARI vs VIR Comparison

ARI vs VIR Comparison

Compare ARI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$11.16

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$10.60

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARI
VIR
Founded
2009
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
ARI
VIR
Price
$11.16
$10.60
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$11.00
$19.63
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
9.03%
N/A
EPS Growth
183.51
17.49
EPS
0.81
N/A
Revenue
$271,589,000.00
$68,556,000.00
Revenue This Year
N/A
$270.22
Revenue Next Year
N/A
N/A
P/E Ratio
$13.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.09
$4.16
52 Week High
$11.24
$10.91

Technical Indicators

Market Signals
Indicator
ARI
VIR
Relative Strength Index (RSI) 64.90 66.51
Support Level $9.59 $5.18
Resistance Level N/A $10.91
Average True Range (ATR) 0.18 0.47
MACD 0.06 0.13
Stochastic Oscillator 89.35 95.34

Price Performance

Historical Comparison
ARI
VIR

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: